학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 5건 | 목록 1~20
Academic Journal
Mangiante L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Department of Medicine, Stanford University, Stanford, CA, USA.; Alcala N; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Sexton-Oates A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Di Genova A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Instituto de Ciencias de la Ingeniería, Universidad de O'Higgins, Rancagua, Chile.; Centro de Modelamiento Matemático UMI-CNRS 2807, Universidad de Chile, Santiago, Chile.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer, Instituto de Salud Carlos III, Madrid, Spain.; Khandekar A; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; Bergstrom EN; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; Kim J; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA.; Department of Computational Biology, Cornell University, Ithaca, NY, USA.; Liu X; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA.; Blazquez-Encinas R; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain.; Giacobi C; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Le Stang N; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.; Boyault S; Cancer Genomic Platform, Translational Research and Innovation Department, Centre Léon Bérard, Lyon, France.; Cuenin C; EpiGenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Tabone-Eglinger S; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.; Damiola F; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.; Voegele C; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Ardin M; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.; Michallet MC; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.; Soudade L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Delhomme TM; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Poret A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Brevet M; Cypath and Cypath-rb, Villeurbanne, France.; Copin MC; University of Lille, Centre Hospitalier Universitaire Lille, Institut de Pathologie, Tumorothèque du Centre de Référence Régional en Cancérologie, Lille, France.; Giusiano-Courcambeck S; Department of Pathology, Centre Hospitalier Universitaire Nord, Marseille, France.; Damotte D; Centre de Recherche des Cordeliers, Inflammation, Complement and Cancer Team, Sorbonne Université, INSERM, Université de Paris, Paris, France.; Department of Pathology, Hôpitaux Universitaire Paris Centre, Tumorothèque/CRB Cancer, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Girard C; Tumorothèque Centre Hospitalier Universitaire de Nantes, Nantes, France.; Hofman V; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, Nice Center Hospital, FHU OncoAge, Biobank BB-0033-00025 and IRCAN Inserm U1081/CNRS 7284, Nice, France.; Hofman P; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, Nice Center Hospital, FHU OncoAge, Biobank BB-0033-00025 and IRCAN Inserm U1081/CNRS 7284, Nice, France.; Mouroux J; Université Côte d'Azur, Department of Thoracic Surgery, Nice Center Hospital, FHU OncoAge and IRCAN Inserm U1081/CNRS 7284, Nice, France.; Cohen C; Department of Thoracic Surgery, FHU OncoAge, Nice Pasteur Hospital, Université Côte d'Azur, Nice, France.; Lacomme S; Nancy Regional University Hospital, Centre Hospitalier Régional Universitaire, CRB BB-0033-00035, INSERM U1256, Nancy, France.; Mazieres J; Toulouse University Hospital, Université Paul Sabatier, Toulouse, France.; de Montpreville VT; Department of Pathology, Marie Lannelongue Hospital, Le Plessis Robinson, France.; Perrin C; Hospices Civils de Lyon, Institut de Pathologie, Centre de Ressources Biologiques des HCL, Tissu-Tumorothèque Est, Lyon, France.; Planchard G; Centre Hospitalier Universitaire de Caen, MESOPATH Regional Center, Caen, France.; Rousseau N; Centre Hospitalier Universitaire de Caen, MESOPATH Regional Center, Caen, France.; Rouquette I; Centre de Pathologie des Côteaux, Centre de Ressources Biologiques (CRB Cancer), IUCT Oncopole, Toulouse, France.; Sagan C; Tumorothèque Centre Hospitalier Universitaire de Nantes, Nantes, France.; Scherpereel A; University of Lille, Centre Hospitalier Universitaire Lille, INSERM, OncoThAI, NETMESO Network, Lille, France.; Thivolet F; Hospices Civils de Lyon, Institut de Pathologie, Centre de Ressources Biologiques des HCL, Tissu-Tumorothèque Est, Lyon, France.; Vignaud JM; Department of Biopathology, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre-les-Nancy, France.; BRC, BB-0033-00035, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre-les-Nancy, France.; Jean D; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, Paris, France.; Ilg AGS; Direction Santé Environnement Travail, Santé Publique France, Paris, France.; Olaso R; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.; Meyer V; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.; Boland-Auge A; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.; Deleuze JF; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.; Altmuller J; Cologne Centre for Genomics, Cologne, Germany.; Nuernberg P; Cologne Centre for Genomics, Cologne, Germany.; Ibáñez-Costa A; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain.; Castaño JP; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain.; Lantuejoul S; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.; Grenoble Alpes University, Saint-Martin-d'Hères, France.; Ghantous A; EpiGenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.; Maussion C; Owkin, New York, NY, USA.; Courtiol P; Owkin, New York, NY, USA.; Hernandez-Vargas H; UMR INSERM 1052, CNRS 5286, UCBL1, Centre Léon Bérard, Lyon, France.; Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Caux C; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.; Girard N; Institut Curie, Institut du Thorax Curie Montsouris, Paris, France.; Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Versailles, France.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer, Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Alexandrov LB; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; Galateau-Salle F; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.; Foll M; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France. follm@iarc.who.int.; Fernandez-Cuesta L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France. fernandezcuestal@iarc.who.int.
Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Academic Journal
Churg A; Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada. achurg@mail.ubc.ca.; Le Stang N; Department of BioPathology Centre Léon Bérard, MESOPATH College, MESONAT, MESOBANK, Lyon, France.; Dacic S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Pissaloux D; Department of Biopathology, Unit of Molecular Pathology and Cancer Research Center of Lyon, INSERM, Lyon, France.; Team Genetics, Epigenetics and Biology of Sarcomas, Univ Lyon, Université Claude Bernard Lyon 1, INSERM, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.; Begueret H; Department of BioPathology Centre Léon Bérard, MESOPATH College, MESONAT, MESOBANK, Lyon, France.; Dartigues P; Department of BioPathology Centre Léon Bérard, MESOPATH College, MESONAT, MESOBANK, Lyon, France.; Giusiano-Courcambeck S; Department of BioPathology Centre Léon Bérard, MESOPATH College, MESONAT, MESOBANK, Lyon, France.; Sequeiros R; Department of BioPathology Centre Léon Bérard, MESOPATH College, MESONAT, MESOBANK, Lyon, France.; Pairon JC; Faculté de médecine and CHI Creteil, Service de Pathologies professionnelles et de l'Environnement, IST-PE, INSERM, UPEC, Creteil, France.; Tirode F; Team Genetics, Epigenetics and Biology of Sarcomas, Univ Lyon, Université Claude Bernard Lyon 1, INSERM, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.; Galateau-Sallé F; Department of BioPathology Centre Léon Bérard, MESOPATH College, MESONAT, MESOBANK, Lyon, France.; Team Genetics, Epigenetics and Biology of Sarcomas, Univ Lyon, Université Claude Bernard Lyon 1, INSERM, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Report
Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Giusiano-Courcambeck, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어